Tommy Thompson, secretary of the United States Department of Health and Human Services, has urged state attorneys general to go after those who they think price influenza vaccines “too high.” The vaccine business is already a high-risk one, due to a limited product shelf life, uncertain demand, and lawsuits. Do threats of price controls make being in the vaccine business more attractive?
The solution to our vaccine problems is not to put one agency in charge but, instead, to reduce the role of government so that the vaccine market acts more like the U.S. bread market and less like the Soviet one.
Comments